APA (7th ed.) Citation

A, D. P., RJ, G., JC, F., JG, M., ES, Z., BM, E., . . . PM, R. (2022). Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. The New England journal of medicine, 387(21), 1923. https://doi.org/10.1056/NEJMoa2210645

Chicago Style (17th ed.) Citation

A, Das Pradhan, et al. "Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk." The New England Journal of Medicine 387, no. 21 (2022): 1923. https://doi.org/10.1056/NEJMoa2210645.

MLA (9th ed.) Citation

A, Das Pradhan, et al. "Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk." The New England Journal of Medicine, vol. 387, no. 21, 2022, p. 1923, https://doi.org/10.1056/NEJMoa2210645.

Warning: These citations may not always be 100% accurate.